Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)

The purpose of this notice of funding opportunity (NOFO) is to continue support for a nonhuman primate (NHP) reagent resource that enables rigorous and reproducible research in NHP models through the development, production, and distribution of NHP-specific immunologic reagents that are not commercially available or, if commercially available, are not optimized for use in NHPs. The over-arching goal is to accelerate cures, vaccines, and treatments for immune-mediated diseases and emerging and reemerging infectious diseases by facilitating robust preclinical research in NHPs. • The resource will support the development, production, and distribution of NHP-specific immunologic reagents. • The reagents will be used to facilitate robust preclinical research in NHPs. • The goal is to accelerate cures, vaccines, and treatments for immune-mediated diseases and emerging and reemerging infectious diseases. • Eligible applicants include State governments, County governments, Nonprofits, Native American tribal governments, Public and State controlled institutions of higher education, and others. • The estimated funding for this opportunity is $1,300,000.